.avif)
Not every man with low testosterone wants or is a candidate for traditional testosterone replacement.
For some men, particularly those concerned about maintaining fertility, a different approach may be worth discussing. Clomiphene citrate (Clomid) and enclomiphene belong to a class of medications called selective estrogen receptor modulators (SERMs). Rather than supplying testosterone from outside the body, these medications can stimulate hormonal signals that encourage the testes to produce more testosterone.
At Healthy Aging Medical Centers of New Jersey, the decision to consider clomiphene or enclomiphene starts with understanding why testosterone is low, your symptoms, laboratory findings, reproductive goals, and overall health.
Low testosterone isn't always a matter of the testes simply failing to make enough testosterone.
The body's hormone system involves communication between the hypothalamus, pituitary gland, and testes. The pituitary produces hormones including LH and FSH, which help regulate testosterone production and sperm production.
In some men with secondary or functional hypogonadism, stimulating this existing hormonal pathway may be a treatment consideration. That's where SERMs such as clomiphene can come into the conversation.
.avif)
Clomiphene citrate is a medication originally approved for certain uses involving female infertility. Its use in men for hypogonadism is off-label, meaning the medication is being prescribed for a use that is not specifically included in its FDA-approved labeling.
It has been studied and used clinically in selected men with testosterone deficiency, particularly when preserving fertility is an important consideration.
Clomiphene works by affecting estrogen feedback in the hypothalamus and pituitary. This can increase signaling through LH and FSH, which may stimulate the testes to produce more testosterone.
.avif)
Enclomiphene is one of the two stereoisomers that make up clomiphene citrate.
It has been investigated as a potential treatment for secondary male hypogonadism because it can stimulate LH and FSH, potentially increasing the body's own testosterone production. Research has also examined its effect on sperm-related measures.
However, enclomiphene is not currently FDA-approved for the treatment of male hypogonadism. Its use in this setting should therefore be discussed carefully with a qualified medical provider.
.avif)
Enclomiphene is one of the two stereoisomers that make up clomiphene citrate.
It has been investigated as a potential treatment for secondary male hypogonadism because it can stimulate LH and FSH, potentially increasing the body's own testosterone production. Research has also examined its effect on sperm-related measures.
However, enclomiphene is not currently FDA-approved for the treatment of male hypogonadism. Its use in this setting should therefore be discussed carefully with a qualified medical provider.
The biggest consideration is often how the treatment affects the body's own hormone production and reproductive function.
Traditional testosterone replacement provides testosterone from outside the body. Exogenous testosterone can suppress the hormonal signals that drive sperm production.
SERMs work differently. By stimulating the body's hormonal signaling, they may increase endogenous testosterone while maintaining or supporting the hormonal environment involved in sperm production. Research has found that SERMs can increase testosterone, LH, and FSH in appropriately selected men.
That doesn't mean these medications are automatically better than testosterone replacement. It means they represent a different treatment strategy for certain patients.
.avif)
.avif)
This is one of the most important reasons a man may ask about clomiphene or enclomiphene.
If you're trying to maintain fertility, conventional testosterone replacement may not be the best starting point because external testosterone can suppress sperm production. SERMs have been studied as alternatives because they stimulate the body's own testosterone-producing pathway rather than replacing testosterone directly.
However, fertility is complex. Increasing testosterone does not guarantee pregnancy or normal fertility, and research on fertility outcomes with SERMs remains mixed. A recent meta-analysis found uncertainty around pregnancy outcomes with clomiphene in men with idiopathic male-factor infertility.
If having children is important to you, that goal should be part of the treatment discussion from the beginning.
Clomiphene or enclomiphene isn't appropriate for every man with a low testosterone result.
Your provider may first evaluate:
The distinction between primary and secondary hypogonadism can be particularly important. SERMs work by stimulating the body's existing hormonal signaling, so the underlying cause of low testosterone matters.
.avif)
.avif)
A low testosterone number shouldn't automatically lead to medication.
Your evaluation may include a detailed discussion of your symptoms, health history, medications, reproductive goals, and previous laboratory results. Additional blood testing may help determine how your hypothalamus, pituitary gland, and testes are functioning.
This information helps your provider decide whether stimulating your body's own testosterone production is a reasonable approach.
Treatment doesn't end when a prescription is provided.
Follow-up may include monitoring testosterone and other hormone levels, reviewing changes in symptoms, assessing side effects, and checking reproductive or other laboratory markers when clinically appropriate.
Research on clomiphene in men has found increases in testosterone and related hormones, but study protocols and patient populations vary. Long-term evidence is not as extensive as it is for some established testosterone therapies. That makes ongoing medical supervision particularly important.
These treatments approach low testosterone differently.
Testosterone replacement: Provides testosterone from an external source.
Clomiphene: Stimulates the body's hormonal signaling to encourage endogenous testosterone production; its use in men is off-label.
Enclomiphene: A component of clomiphene that has been studied as a SERM for male hypogonadism but is not currently FDA-approved for this indication.
The appropriate choice depends on the cause of testosterone deficiency, symptoms, reproductive goals, health history, and medical evaluation.
Clomiphene and related SERMs can cause side effects, and they are not appropriate for everyone.
Reported effects with clomiphene in men have included headache, dizziness, gynecomastia, and mood or psychiatric effects. Visual symptoms have also been reported with clomiphene use and should be discussed promptly with a healthcare provider.
Your provider should review the potential risks and benefits before treatment and determine what monitoring is appropriate.
Healthy Aging Medical Centers of New Jersey provides men's hormone and healthy-aging care at two New Jersey locations:
Whippany Office
91 S Jefferson Rd Whippany, NJ 07981
Hazlet Office
155 Middle Rd Hazlet, NJ 07730
Johanan Rand, M.D., and the medical team can evaluate whether your symptoms and hormone profile are consistent with testosterone deficiency and discuss treatment approaches that align with your health and reproductive goals.
If you're dealing with low testosterone but don't want to assume that traditional testosterone replacement is your only option, a medical evaluation can help clarify the choices.
For some men, particularly those concerned about fertility or maintaining the body's own testosterone production, Clomid or enclomiphene may be worth discussing with a qualified provider.
Healthy Aging Medical Centers of New Jersey provides men's hormone care in Whippany and Hazlet, serving patients throughout New Jersey.
For some men, clomiphene may be considered as an alternative approach, particularly when maintaining endogenous testosterone production and fertility is important. However, clomiphene is used off-label in men, and it is not appropriate for every cause of low testosterone.
Clomiphene can increase the hormonal signals that stimulate the testes, which can lead to higher endogenous testosterone in appropriately selected men. Clinical studies have reported increases in testosterone, LH, and FSH.
No. Enclomiphene is not currently FDA-approved for treating male hypogonadism. It has been studied for this purpose and may be used off-label in some clinical settings.
Unlike external testosterone, clomiphene stimulates the body's own hormonal signaling. This may allow testosterone levels to increase without the same direct suppression of sperm production associated with testosterone replacement. Fertility outcomes are individual, however, and treatment should be guided by appropriate evaluation.
Don't combine or switch hormone medications without medical supervision. Your provider would need to review your current treatment, testosterone levels, symptoms, and treatment goals before determining whether a different approach makes sense.
Your provider may monitor hormone levels and symptoms over time rather than judging the treatment from an immediate change. The appropriate follow-up interval depends on your treatment plan and clinical circumstances.
No. Enclomiphene is one of the two stereoisomers contained in clomiphene citrate. They are related but are not identical medications.
No. The underlying cause of testosterone deficiency matters. A medication that stimulates the body's hormonal signaling may not be appropriate when the testes cannot respond adequately or when another medical condition is responsible for the low testosterone.
Healthy Aging Medical Centers of New Jersey has offices in Whippany and Hazlet. A medical evaluation can help determine whether your symptoms and laboratory findings warrant treatment and which options may be appropriate.
With locations in Whippany, Hazlet, and Miami, we provide personalized medical, wellness, longevity, and aesthetic care designed around your individual health needs.